MNKD FDA Releases Afrezza From Pulmonary Trial, Pediatric sBLA Under Review
Mannkind Corporation · PHARMACEUTICAL PREPARATIONS · Now $3.53
+6.8% in 1d after detection
Post-detection moves
1h
-1.5%
1d
+6.8%
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS